logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Cellular Biomedicine 西比曼生物

CBMG Announces Plans to Build US R&D Facility for Immunotherapies

Oct 8, 2019

Life Science

Guanhao Biotech

Guanhao Bio Pays $3.1 Million to Acquire Stake in US-based ZY Therapeutics

Sep 26, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Clinical Data Published from RepliCel’s Skin Rejuvenation Study

Sep 24, 2019

Life Science

Shanghai Pharmaceuticals

Shanghai Pharma Forms $250 Million China Antibody JV with Russia’s Biocad

Sep 18, 2019

Life Science

Genenta Science

Genenta Science of Milan Raises $14.6 Million in Funding Led by China Investor

Sep 13, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Closes First Tranche of Private Placement Financing of Preferred Shares

Sep 13, 2019

Life Science

Henlius

Henlius Biotech Prices Hong Kong IPO to Raise $477 Million

Sep 12, 2019

Life Science

SoliPharma

SoliPharma of Hangzhou Raises $36.5 Million to Develop High End Generics

Sep 12, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel’s Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China

Sep 11, 2019

Life Science

Sichuan Clover

Sichuan Clover Doses First Patient in China Trial of Novel Cancer Biologic

Sep 11, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Correction to Previous Press Release: RepliCel Life Sciences Announces Debt Settlement

Sep 10, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector

Aug 30, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Debt Settlement

Aug 30, 2019

Life Science

Pfizer

Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs

Aug 23, 2019

Life Science

Thermo Fisher

US Medical Device Maker Thermo Fisher to Build New China Factory

Aug 23, 2019

Life Science, Technology

CStone,基石药业

CStone to Begin Australian Trials of Solid Tumor Cancer Drug

Aug 23, 2019

Life Science

Luye Pays $5 Million Upfront for China Rights to PharmaMar's SCLC Treatment,绿叶制药获美国PharmaMar的SCLC治疗药物授权

Luye Pharma Approved to Start Japan Trials of Novel Anti-depressant

Aug 23, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Amendment to Private Placement of Preferred Shares

Aug 22, 2019

Life Science

  • ‹‹ Previous
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada